tm logo

Monitor this mark

View On USPTO

RYLYX
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 09 Dec 2024

Last Applicant/ Owned by

EyePoint Pharmaceuticals US, Inc.

480 Pleasant Street

Watertown

MA

02472

Serial Number

97724887 filed on 20th Dec 2022

Registration Number

N/A

Correspondent Address

Kimberly A Jarman

Kimberly A Jarman

C400

WATERTOWN, MA 02472

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RYLYX

Pharmaceutical preparations for the treatment of eye diseases and conditions

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of eye diseases and conditions

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97724887

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
09th Dec 2024SOU EXTENSION 2 FILED
09th Dec 2024SOU EXTENSION 2 GRANTED
09th Dec 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09th Dec 2024SOU TEAS EXTENSION RECEIVED
20th Jun 2024SOU EXTENSION 1 FILED
20th Jun 2024SOU EXTENSION 1 GRANTED
20th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20th Jun 2024SOU TEAS EXTENSION RECEIVED
26th Dec 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
31st Oct 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED